Long-lasting decrease of marrow and circulating long-term culture initiating cells after allogeneic bone marrow transplant

Bone Marrow Transplantation

Volumn 23, Issue 10, 1999, Pages 1029-1037

  Selleri, C ^a   Maciejewski, J P ^b   De Rosa, G ^a   Raiola, A ^a   Risitano, A M ^a   Picardi, M ^a   Pezzullo, L ^a   Luciano, L ^a   Ricci, P ^a   Varriale, G ^a   Della Cioppa, P ^a   Del Vecchio, L ^c   Rotoli, B ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c CARDARELLI HOSPITAL   (Italy)

Author keywords

BMT; CD34+; LTC IC

Indexed keywords

CD34 ANTIGEN; METHYLCELLULOSE;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BLOOD CELL COUNT; BONE MARROW CELL; CLINICAL ARTICLE; COLONY FORMING UNIT GM; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL;

EID: 0032971197     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701759     Document Type: Article

References (34)

1. Arnold R, Schmeiser T, Heit W et al. Hemopoietic reconstitution after bone marrow transplantation. Exp Hematol 1986; 14: 271-277.
2. Vellega E, Sizoo W, Hagenbeeck A et al. Different repopulation kinetics of erythroid (BFU-E), myeloid (CFU-GM) and T-lymphocyte (TL-CFU) progenitor cells after autologous and allogeneic bone marrow transplant. Br J Haematol 1987; 65: 137-142.
3. Betticher DC, Huxol H, Muller R et al. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia. Exp Hematol 1993; 21: 1517-1521.
4. Bacigalupo A, Piaggio G, Podestà M et al. Influence of marrow CFU-GM content on engraftment and survival after allogeneic bone marrow transplant. Bone Marrow Transplant 1995; 15: 221-225.
5. dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. Blood 1995; 86: 2842-2848.
6. Kirkland MA, Spencer A, Davidson RJ et al. Quantitation of mafosfamide-resistant pre-colony-forming units in allogeneic bone marrow transplantation: relationship with rate of engraftment and evidence for long-lasting reduction in stem cell numbers. Blood 1996; 87: 3963-3969.
7. + peripheral blood progenitor cell dose on hematopoietic recovery. Biol Blood Marrow Transplant 1998; 4: 84-92.
8. Maciejewski JP, Selleri C, Sato T et al. A severe and consistent deficit in marrow and circulating primitive hematopoietic cells (long-term culture initiating cells) in acquired aplastic anemia. Blood 1996; 88: 1983-1989.
9. Podestà M, Piaggio G, Frassoni F et al. Deficient reconstitution of early progenitors after allogeneic bone marrow transplantation. Bone Marrow Transplant 1997; 19: 1011-1017.
10. Podestà M, Piaggio G, Frassoni F et al. The assessment of the hematopoietic reservoir after immunosuppressive therapy or bone marrow transplantation in severe aplastic anemia. Blood 1998; 91: 1959-1965.
11. Novitzky N, Mohamed R. Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation. Exp Hematol 1995; 23: 1661-1666.
12. Novitzky N, Mohammed R. Alterations in the progenitor cell population follow recovery from myeloablative therapy and bone marrow transplantation. Exp Hematol 1997; 25: 471-477.
13. O'Flaherty E, Sparrow R, Szer J. Bone marrow stromal function from patients after bone marrow transplantation. Bone Marrow Transplant 1995; 15: 207-212.
14. Piacibello W, Sanavio F, Garetto L et al. Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood 1997; 89: 2644-2653.
15. Brandt JE, Galy AHM, Luens KM et al. Bone marrow repopulation by human marrow stem cells after long-term expansion culture on a porcine endothelial cell line. Exp Hematol 1998; 26: 950-961.
16. Peters SO, Kittler ELW, Ramshaw et al. Ex vivo expansion of murine marrow cells with interleukin-3 (IL3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. Blood 1996; 87: 30-37.
17. Yonemura Y, Ku H, Hirahama F et al. Interleukin 3 or interleukin 1 abrogates the reconstituting ability of hematopoietic stem cells. Proc Natl Acad Sci USA 1996; 93: 4040-4044.
18. Engelhardt M, Kumar R, Albanell J et al. Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells. Blood 1997; 90: 182-193.
19. Notare R, Cimmino A, Tabarini D et al. In vivo telomere dynamics of human hematopoietic stem cells. Proc Natl Acad Sci USA 1997; 94: 13782-13785.
20. Wynn RF, Cross MA, Hatton C et al. Accelerated telomere shortening in young recipients of allogeneic bone marrow transplants. Lancet 1998; 351: 178-181.
21. Akiyama M, Hoshi Y, Sakurai S et al. Changes of telomere length in children after hematopoietic stem cell transplantation. Bone Marrow Transplant 1998; 21: 67-71.
22. Broccoli D, Young GW, de Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 1995; 92: 9082-9086.
23. Neben S, Hemman S, Montgomery M et al. Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents. Exp Hematol 1993; 21: 156-162.
24. Mauch P, Rosenblatt M, Hellmann S. Permanent loss in stem cell self-renewal capacity following stress in the marrow. Blood 1988; 72: 1193-1196.
25. Zijlmans JMJM, Visser JWM, Laterveer L et al. The early phase of engraftment after murine blood cell transplantation is mediated by hematopoietic stem cells. Proc Natl Acad Sci USA 1998; 95: 725-729.
26. low primitive cells capable of reconstituting long-term cultures in vitro and nonobese diabetic-severe combined immunodeficiency mice in vivo. Hum Gene Ther 1998; 9: 1497-1511.
27. Zijlmans JMJM, Visser JWM, Kleiverda K et al. Modification of rhodamine staining allows identification of hematopoietic stem cells with preferential short-term or long-term bone marrow-repopulating ability. Proc Natl Acad Sci USA 1995; 92: 8901-8905.
28. Taswell C. Limiting dilution analysis for the determination of immunocompetent cell frequencies. J Immunol 1981; 126: 1614-1619.
29. Lansdorp PM. Self-renewal of stem cells. Biol Blood Marrow Transplant 1997; 3: 171-178.
30. Pawliuk R, Eaves C, Humphries RK. Evidence of both ontogeny and transplant dose-regulated expansion of hematopoietic stem cells in vivo. Blood 1996; 88: 2852-2858.
31. McKinstry WJ, Li CL, Rasko JEJ et al. Cytokine receptor expression on hematopoietic stem and progenitor cells. Blood 1997; 89: 65-71.
32. Reisner Y, Martelli MF. Bone marrow transplantation across HLA barriers by increasing the number of transplanted cells. Immunol Today 1995; 16: 437-440.
33. + cells. Blood 1994; 84: 2930-2939.
34. Schmitz N, Bacigalupo A, Hasenclever D et al. Allogeneic bone marrow transplantation vs filgrastim-mobilized peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1998; 21: 995-1003.